Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32019
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Admojo, Lorenztino | - |
dc.contributor.author | Korte, James | - |
dc.contributor.author | Anderson, Nigel | - |
dc.contributor.author | Phillips, Claire | - |
dc.contributor.author | Caspersz, Lauren | - |
dc.contributor.author | Lasocki, Arian | - |
dc.date | 2023 | - |
dc.date.accessioned | 2023-01-24T03:20:06Z | - |
dc.date.available | 2023-01-24T03:20:06Z | - |
dc.date.issued | 2023-01-17 | - |
dc.identifier.citation | Journal of Medical Imaging and Radiation Oncology 2023; 67(3) | en_US |
dc.identifier.issn | 1754-9485 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/32019 | - |
dc.description.abstract | The incidence of radionecrosis (RN) after stereotactic radiosurgery (SRS) to brain metastases is increasing. An overlap in the conventional MRI appearances of RN and tumour recurrence (TR) is diagnostically challenging. Delayed contrast MRI compares contrast enhancement over two time periods to create treatment response assessment maps (TRAMs). We aim to assess the utility of TRAMs in brain metastases patients. | en_US |
dc.language.iso | eng | - |
dc.subject | brain metastases | en_US |
dc.subject | delayed contrast MRI | en_US |
dc.subject | radionecrosis | en_US |
dc.subject | stereotactic radiosurgery | en_US |
dc.subject | treatment response assessment maps | en_US |
dc.title | Investigating the role of delayed contrast magnetic resonance imaging (MRI) to differentiate radiation necrosis from tumour recurrence in brain metastases after stereotactic radiosurgery. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Journal of Medical Imaging and Radiation Oncology | en_US |
dc.identifier.affiliation | Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. | en_US |
dc.identifier.affiliation | Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. | en_US |
dc.identifier.affiliation | Austin Health | en_US |
dc.identifier.doi | 10.1111/1754-9485.13504 | en_US |
dc.type.content | Text | en_US |
dc.identifier.orcid | 0000-0002-3674-6205 | en_US |
dc.identifier.orcid | 0000-0001-8176-3015 | en_US |
dc.identifier.pubmedid | 36650724 | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | Journal Article | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.